TET2 promoter methylation in low-grade diffuse gliomas lacking IDH1/2 mutations.

@article{Kim2011TET2PM,
  title={TET2 promoter methylation in low-grade diffuse gliomas lacking IDH1/2 mutations.},
  author={Youngho Kim and Daniela Pierscianek and Michel Mittelbronn and Anne Vital and Luigi Mariani and Martin Hasselblatt and Hiroko Ohgaki},
  journal={Journal of clinical pathology},
  year={2011},
  volume={64 10},
  pages={850-2}
}
BACKGROUND Miscoding mutations of the TET2 gene, which encodes the α-ketoglutarate-dependent enzyme that catalyses the conversion of 5-methylcytosine to 5-hydroxymethylcytosine, thus producing DNA demethylation, have been detected in 10-25% of acute myeloid leukaemias lacking IDH1/2 mutations. Most low-grade diffuse gliomas carry IDH1/2 mutations (>85%), but molecular mechanisms of pathogenesis in those lacking IDH1/2 mutations remain to be elucidated. METHODS Miscoding mutations and promoter… CONTINUE READING

From This Paper

Topics from this paper.
33 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 33 extracted citations

Similar Papers

Loading similar papers…